This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
This week’s new post on the CLL Society’s website brings us practical advice from Dr. Neil Kay out of the Mayo clinic on prognostic indicators and how to manage early stage CLL (chronic lymphocytic leukemia). He also discusses MBL or monoclonal B cell lymphocytosis a precursor to CLL.
Dr. Kay’s lecture and my commentary from the robust but accessible CLL Research Consortium (CRC) Patient Empowerment and Education Conference in April 2015 in San Diego at UCSD can be found under conference coverage here.
If you haven’t already seen Dr. Kipps’ incredible overview of CLL and the work the CRC does, please catch it here.
If you haven’t done so already, we encourage you to please sign up to receive alerts regarding new postings and for our quarterly newsletters (first one will be published in September) and to share with other patients, caregivers or concerned family or anyone whose life is touched by CLL.
We are all in this together.
Brian Koffman, MD
Volunteer Medical Director CLL Society